Skip to content

Changes of CYP17A1 and CYP11A1 concentrations in serum and follicular fluid of patients with polycystic ovary syndrome and their correlation with insulin resistance

Changes of CYP17A1 and CYP11A1 concentrations in serum and follicular fluid of patients with polycystic ovary syndrome and their correlation with insulin resistance

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046605
Enrollment
Unknown
Registered
2021-05-22
Start date
2021-05-30
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome

Interventions

PCOS patients with or without insulin resistance group, insulin resistant patients, normal control group:Nil

Sponsors

The Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis of PCOS is based on the diagnostic criteria of the European Society of Human Reproduction and Embryology in Rotterdam and the American Society of Reproductive Medicine (ESHRE/ASRM) in 2003, which stipulate that the diagnosis requires any 2 of the following 3 items: (1) Rare ovulation and/or anovulation; (2) Clinical manifestations and/or excessive androgen; (3) Ultrasound detection of ovarian polycystic changes, that is, >=12 follicles with a diameter of 2-9mm in one or two ovaries, or ovarian volume >=10 ml; 2. All patients were evaluated with positive glucose hyperinsulinemic clamp (EHC) technology; M value (glucose metabolism rate) less than 6.286 mg/kg/min indicates IR, and M value greater than or equal to 6.286 mg/kg/min indicates non-IR.

Exclusion criteria

Exclusion criteria: 1. Aged over 40 years; 2. Body mass index (BMI) is greater than 35 kg/m2; 3. There are other diseases that cause infertility; 4. There are obvious signs or symptoms of liver and kidney disease, alanine aminotransferase is higher than 2 times the normal value, serum creatinine is higher than normal, severe gallstones, triglycerides higher than 5mmol/L, heart failure, thyroid disease, Or have a history of diabetes; 5. Use of drugs that affect glucose and lipid metabolism within the last 3 months; 6. A history of mental disorders or alcohol or drug abuse in the past 3 years; 7. Have a history of allergies or contraindications to the study drug (Exenatide (EX) injection); 8. Positive urine HCG or reluctance to take strict contraceptive measures during the research process; 9. Participate in other drug trials.

Design outcomes

Primary

MeasureTime frame
CYP17A1;

Countries

China

Contacts

Public ContactLiao Xin

The Affiliated Hospital of Zunyi Medical University

liaoxin8618@163.com+86 13595208618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026